Coherus Biosciences | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Acadia Pharmaceuticals USD 244.32M 15.28M 2025-03
ALKERMES USD 306.5M 123.5M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
Amarin USD 42.02M 20.29M 2025-03
Amgen USD 8.15B 936M 2025-03
Baxter International USD 2.63B 123M 2025-03
Biogen USD 2.43B 24.7M 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Fujifilm JPY 868.31B 55.54B 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
Ironwood Pharmaceuticals USD 90.54M 1.05M 2024-12
Merck USD 15.53B 94M 2025-03
Myriad Genetics USD 195.9M 14.7M 2025-03
Pacira USD 168.92M 18.33M 2025-03
Perrigo USD 1.04B 98.3M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
PTC Therapeutics USD 190M 23.17M 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Sarepta Therapeutics USD 774.9M 116.49M 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03
Xencor USD 32.73M 37.29M 2025-03
Zoetis USD 2.22B 97M 2025-03



Coherus Biosciences Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.